🇺🇸 FDA
Pipeline program

Intravenous stem cell transplantation

201400000003-2

Phase 1 gene_therapy active

Quick answer

Intravenous stem cell transplantation for Stroke is a Phase 1 program (gene_therapy) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
Stroke
Phase
Phase 1
Modality
gene_therapy
Status
active

Clinical trials